These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 11137710
21. Characterization of an anthracycline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression. Jönsson K, Dahlberg N, Tidefelt U, Paul C, Andersson G. Biochem Pharmacol; 1995 Mar 15; 49(6):755-62. PubMed ID: 7702633 [Abstract] [Full Text] [Related]
22. Expression and functional activity of P-glycoprotein in cultured hepatocytes from Oncorhynchus mykiss. Sturm A, Ziemann C, Hirsch-Ernst KI, Segner H. Am J Physiol Regul Integr Comp Physiol; 2001 Oct 15; 281(4):R1119-26. PubMed ID: 11557618 [Abstract] [Full Text] [Related]
23. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells. Budworth J, Davies R, Malkhandi J, Gant TW, Ferry DR, Gescher A. Br J Cancer; 1996 May 15; 73(9):1063-8. PubMed ID: 8624264 [Abstract] [Full Text] [Related]
24. Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. Hu Y, Moraes CT, Savaraj N, Priebe W, Lampidis TJ. Biochem Pharmacol; 2000 Dec 15; 60(12):1897-905. PubMed ID: 11108806 [Abstract] [Full Text] [Related]
25. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line. Naito S, Hasegawa S, Yokomizo A, Koga H, Kotoh S, Kuwano M, Kumazawa J. Jpn J Cancer Res; 1995 Nov 15; 86(11):1112-8. PubMed ID: 8567404 [Abstract] [Full Text] [Related]
26. Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21. Seemann O, Muscheck M, Siegsmund M, Pilch H, Nebe CT, Rassweiler J, Alken P. Urol Res; 1995 Nov 15; 22(6):353-60. PubMed ID: 7740654 [Abstract] [Full Text] [Related]
27. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z. Mol Med Rep; 2016 Jun 15; 13(6):4745-50. PubMed ID: 27082231 [Abstract] [Full Text] [Related]
28. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Abe T, Koike K, Ohga T, Kubo T, Wada M, Kohno K, Mori T, Hidaka K, Kuwano M. Br J Cancer; 1995 Aug 15; 72(2):418-23. PubMed ID: 7640227 [Abstract] [Full Text] [Related]
29. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Zhu CY, Lv YP, Yan DF, Gao FL. Asian Pac J Cancer Prev; 2013 Aug 15; 14(11):6757-60. PubMed ID: 24377601 [Abstract] [Full Text] [Related]
30. Characterization of multidrug-resistant pituitary tumor cells. Nelson EJ, Hinkle PM. Endocrinology; 1992 Jun 15; 130(6):3246-56. PubMed ID: 1350759 [Abstract] [Full Text] [Related]
31. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Hu XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A, Zalcberg JR. Br J Cancer; 1995 May 15; 71(5):931-6. PubMed ID: 7734315 [Abstract] [Full Text] [Related]
32. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W, Meng Q, Sun Y, Wang C, Huo X, Liu Z, Sun P, Sun H, Ma X, Liu K. Cell Physiol Biochem; 2018 May 15; 51(4):1616-1631. PubMed ID: 30497065 [Abstract] [Full Text] [Related]
33. Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. Magnarin M, Morelli M, Rosati A, Bartoli F, Candussio L, Giraldi T, Decorti G. Eur J Pharmacol; 2004 Jan 01; 483(1):19-28. PubMed ID: 14709322 [Abstract] [Full Text] [Related]
34. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells. Han F, Liu G, Sun C, Wei J. Cell Mol Biol (Noisy-le-grand); 2018 Dec 31; 64(15):55-61. PubMed ID: 30672437 [Abstract] [Full Text] [Related]
35. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3. Ernest S, Bello-Reuss E. Am J Physiol; 1996 Mar 31; 270(3 Pt 1):C910-9. PubMed ID: 8638674 [Abstract] [Full Text] [Related]
36. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD, Waalkes MP. Mol Pharmacol; 2001 Aug 31; 60(2):302-9. PubMed ID: 11455017 [Abstract] [Full Text] [Related]
37. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Cleary I, Doherty G, Moran E, Clynes M. Biochem Pharmacol; 1997 May 15; 53(10):1493-502. PubMed ID: 9260877 [Abstract] [Full Text] [Related]
38. Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-lines. Bashir I, Sikora K, Abel P, Foster CS. Int J Cancer; 1994 Jun 01; 57(5):719-26. PubMed ID: 7910810 [Abstract] [Full Text] [Related]
39. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Sharom FJ, Yu X, Lu P, Liu R, Chu JW, Szabó K, Müller M, Hose CD, Monks A, Váradi A, Seprôdi J, Sarkadi B. Biochem Pharmacol; 1999 Aug 15; 58(4):571-86. PubMed ID: 10413294 [Abstract] [Full Text] [Related]
40. Renal excretion of rhodamine 123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. Kunihara M, Nagai J, Murakami T, Takano M. J Pharm Pharmacol; 1998 Oct 15; 50(10):1161-5. PubMed ID: 9821664 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]